January 24, 2024 11:11 AM EST
News Briefing

Ku­ra’s $150M PIPE; Lil­ly’s in­vest­ment in Prism Bi­o­Lab; An­no­vis de­lays PhI­II da­ta, cit­ing ‘da­ta clean­ing’

Lei Lei Wu

News Reporter

Jaimy Lee

Deputy Editor

Plus, news about IMU Bio­sciences, ZWI Ther­a­peu­tics and Sagimet Bio­sciences:

Ku­ra On­col­o­gy’s $150M PIPE: The biotech is rais­ing funds from a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times